Pedro Garcia-Fortea

Pedro Garcia-Fortea

Auto-generated profile, based on publicly available information

Pedro Garcia-Fortea

Equipo provincial de Inspección de Málaga, Consejería de Salud de la Junta de Andalucía, Calle Córdoba 11, 29001 Málaga, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Forensic Science International
Verified
Journal Article
Closed access
SMStella Martin-de-las-Heras
Stella Martin-de-las-Heras
PGPedro García-Fortea
Pedro García-Fortea
AOAngie Ortega
Angie Ortega
SZSara Zodocovich
Sara Zodocovich
AVAurora Valenzuela
Aurora Valenzuela

18 November 2013 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
PDF file
PGPedro García-Fortea
Pedro García-Fortea
Ernesto González-MesaErnesto González-Mesa
Ernesto González-Mesa
MBMarta Blasco
Marta Blasco
OCOlga Cazorla
Olga Cazorla
MDM. Delgado-Ríos
M. Delgado-Ríos
MGMaría J. González-Valenzuela
María J. González-Valenzuela
Objective: The relationship between labor physiology and the onset of lactation leads to assess the potential correlation between oxytocin administration during labor and duration of breast-feeding. Methods: This study was designed as a retrospective cohort study where patients given synthetic oxytocin during labor induction were considered as the exposed cohort, and patients not given oxytocin formed the non-exposed cohort. Four hundred of the 7465 children born at our maternity during 2006 were randomly selected. Information about breast-feeding was available for 316 of these children. Eventual confounding or adjustment factors were analyzed using stratified and multivariate analysis. Results: Oxytocin was used for delivery of 189 (59.8%) newborns, multiplying the risk of bottle-feeding by 1.451 (95% CI 1.28–1.63). The best-fit regression model of oxytocin use effect on bottle-feeding included sex and gestational age of the newborn. The use of oxytocin also multiplies the risk of breast-feeding withdrawal at 3 months by 2.29 (95% CI 1.41–3.74). This effect is confounded by maternal age, being higher for mothers under 27 years. Conclusion: Oxytocin administration during labor had some impact on both onset and duration of breast-feeding, particularly in mothers under 27 years of age and newborns delivered at term. Clinical Study registered at U.S. NIH, ID: NCT01951040.

1 November 2007 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
RLRosa López-Gigosos
Rosa López-Gigosos
PGP. García-Fortea
P. García-Fortea
ERE. Reina-Doña
E. Reina-Doña
EPE. Plaza-Martín
E. Plaza-Martín

1 April 2018 in Reproductive Toxicology
Verified
Journal Article
Closed access
PGPedro García-Fortea
Pedro García-Fortea
ICIsaac Cohen-Corcia
Isaac Cohen-Corcia
JCJuan Antonio Córdoba-Doña
Juan Antonio Córdoba-Doña
ARAlberto Reche-Rosado
Alberto Reche-Rosado
Ernesto González-MesaErnesto González-Mesa
Ernesto González-Mesa

16 May 2009 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
RLRosa López-Gigosos
Rosa López-Gigosos
PGPedro Garcia-Fortea
Pedro Garcia-Fortea
MCMaria J Calvo
Maria J Calvo
EREmilia Reina
Emilia Reina
RDRosa Diez-Diaz
Rosa Diez-Diaz
EPElena Plaza
Elena Plaza
Nowadays there is a debate about the indication of the oral whole-cell/recombinant B-subunit cholera vaccine (WC/rBS) in traveller's diarrhoea. However, a cost-benefit analysis based on real data has not been published.

11 June 2014 in Journal of Clinical and Experimental Neuropsychology
Verified
Journal Article
Closed access
MGMaría José González-Valenzuela
María José González-Valenzuela
PGPedro García-Fortea
Pedro García-Fortea
MDMyriam Delgado-Ríos
Myriam Delgado-Ríos
OCOlga Cazorla-Granados
Olga Cazorla-Granados
MAMARTA BLASCO ALONSO
MARTA BLASCO ALONSO
Ernesto González-MesaErnesto González-Mesa
Ernesto González-Mesa
Objective: The objective was to evaluate the potential influence of oxytocin administered during delivery on children’s development at the age of 5. Method: This study was designed as a retrospective cohort study where children from patients given synthetic oxytocin during delivery were considered as the exposed cohort and children from patients not given oxytocin as the nonexposed cohort. From a total of 7465 births attended at our maternity ward in 2006, an initial sample of 400 was randomly selected. A total of 148 children were evaluated using the Battelle Developmental Inventory. Potential confounding and adjustment factors were analyzed using stratified analysis and multivariate analysis (logistic regression). Results: Oxytocin use did not significantly affect the overall risk of developmental delay in the study sample (relative risk, RR, 1.46; 95% confidence interval, CI [0.79–2.71]). The best fit regression model included twin delivery, type of delivery, and maternal age. In the group of vaginal noninstrumental deliveries, oxytocin administration increased the risk of poor Battelle Developmental Inventory outcome, particularly when maternal age was under 28 or over 35 years of age (odds ratio, OR, 67.14; 95% CI [5.46–824.86]). When delivery was instrumental or through cesarean section in mothers aged 28–35 years, oxytocin administration decreased the risk of developmental disorders (OR 0.16; 95% CI [0.04–0.66]). Conclusion: Although oxytocin administration during delivery did not affect the overall risk of low Battelle Developmental Inventory scores in the study sample, some effects were seen according to maternal age and type of birth.